Tucson biotech firm HTG about to go public

Homegrown Tucson biotech company HTG Molecular Diagnostics Inc. plans to go public as soon as next week with an initial public stock offering expected to raise up to $60 million. The company has had longstanding support from local investors including the Desert Angels.

Click here for full article